Log In
BCIQ
Print this Print this
 

Next-generation OvPlex panel

  Manage Alerts
Collapse Summary General Information
Company HealthLinx Ltd.
DescriptionNext-generation ovarian cancer diagnostic designed to examine 7 biomarkers
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/13/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today